anmelden
FTSE All-Share
5.576,38
PKT
-20,66
PKT
-0,37
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 25.10.12 | BAT hold | Société Générale Group S.A. (SG) | |
| 25.10.12 | Barclays buy | Citigroup Corp. | |
| 24.10.12 | HSBC buy | Citigroup Corp. | |
| 24.10.12 | BP outperform | Credit Suisse Group | |
| 24.10.12 | Imperial Brands neutral | Goldman Sachs Group Inc. | |
| 24.10.12 | ITV buy | Nomura | |
| 24.10.12 | National Grid overweight | Morgan Stanley | |
| 24.10.12 | BAE Systems equal-weight | Morgan Stanley | |
| 24.10.12 | BP outperform | RBC Capital Markets | |
| 24.10.12 | Lloyds Banking Group overweight | HSBC | |
| 24.10.12 | Diageo halten | Independent Research GmbH | |
| 23.10.12 | BP neutral | Exane-BNP Paribas SA | |
| 23.10.12 | BP buy | UBS AG | |
| 23.10.12 | BP hold | Société Générale Group S.A. (SG) | |
| 23.10.12 | Barclays neutral | HSBC | |
| 23.10.12 | BP halten | Independent Research GmbH | |
| 23.10.12 | Barclays outperform | Exane-BNP Paribas SA | |
| 23.10.12 | Unilever outperform | Cheuvreux SA | |
| 23.10.12 | BP neutral | Sarasin Research | |
| 23.10.12 | AstraZeneca neutral | Exane-BNP Paribas SA | |
| 23.10.12 | Lloyds Banking Group reduce | Nomura | |
| 26.10.12 | N.Brown Group buy | UBS AG | |
| 23.10.12 | Babcock International overweight | J.P. Morgan Cazenove | |
| 23.10.12 | BAT hold | Société Générale Group S.A. (SG) | |
| 23.10.12 | GSK buy | Société Générale Group S.A. (SG) | |
| 22.10.12 | BP outperform | RBC Capital Markets | |
| 22.10.12 | Anglo American sector perform | RBC Capital Markets | |
| 22.10.12 | BP buy | Deutsche Bank AG | |
| 22.10.12 | Vodafone Group overweight | Morgan Stanley | |
| 22.10.12 | Imperial Brands underperform | Exane-BNP Paribas SA | |
| 22.10.12 | Diageo buy | Société Générale Group S.A. (SG) | |
| 19.10.12 | Whitbread overweight | J.P. Morgan Cazenove | |
| 19.10.12 | BP neutral | Sarasin Research | |
| 23.10.12 | Shell (ex Royal Dutch Shell) outperform | Exane-BNP Paribas SA | |
| 19.10.12 | Diageo overweight | Morgan Stanley | |
| 19.10.12 | Barclays neutral | Sarasin Research | |
| 19.10.12 | Rio Tinto kaufen | Fuchsbriefe | |
| 18.10.12 | GSK neutral | UBS AG | |
| 18.10.12 | Glencore buy | UBS AG | |
| 18.10.12 | Legal General buy | Nomura |